GlassScriptPhysician profile
Janice B Rivera
NPI 1861554677
$4,253.74
in general payments reported to CMS, 2019-2025
16 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $714 · 2022: $508 · 2023: $810 · 2024: $713 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,776 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.54 |
| Travel and Lodging | $256.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,500.04 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $788.92 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Curonix LLC | $196.58 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $191.89 | 2021-2025 | |
| Medtronic, INC. | $191.01 | 2022-2024 | Closurefast |
| Vertos Medical, INC. | $114.19 | 2024 | Mild Device Kit |
| Alexion Pharmaceuticals, INC. | $57.57 | 2024-2025 | Ultomiris |
| Allergan, INC. | $34.55 | 2021 | |
| Ibsa Pharma INC. | $34.45 | 2021 | |
| Protega Pharmaceutials INC | $32.16 | 2025 | Roxybond |
| Genentech USA, INC. | $23.82 | 2024 | Ocrevus Zunovo |
| Scilex Pharmaceuticals INC. | $20.37 | 2024 | |
| Biodelivery Sciences International, INC. | $17.59 | 2021 | |
| Spr Therapeutics, INC | $16.96 | 2022 | |
| Relievant Medsystems, INC. | $16.96 | 2023 | Intracept |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $16.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.